HOVON110/ReBeL Study: Results of the Phase I Part of a Randomized Phase I/II Study of Lenalidomide, Rituximab With or Without Bendamustine in Patients With Relapsed/Refractory Follicular Lymphoma

WBC Stevens, Katerina Bakunina, M Cuijpers, M Chamuleau, A Beeker, R Fijnheer, H Hebart, HPJ Visser, Jeanette Doorduijn, K Linton, M Dreyling, D Jong, MJ Kersten

Research output: Contribution to journalArticleAcademicpeer-review

3 Citations (Scopus)
16 Downloads (Pure)
Original languageEnglish
Article numbere325
Issue number1
Publication statusPublished - 2020

Research programs

  • EMC OR-01

Cite this